BritePear›Research›GLOW Blend
Research · Skin & Recovery Blends
Compounding Gray Area

GLOW, The Three-Peptide Blend

BPC-157, TB-500, and GHK-Cu combined into one protocol. Why these three peptides are stacked together, and what each one is doing.

🍐 Pear It Down —

GLOW is a combination blend of three peptides, BPC-157, TB-500, and GHK-Cu, formulated together rather than dosed separately. It is one of the most requested blends in the skin and recovery peptide community. Each component has its own research base; the blend itself is a compounding pharmacy convenience, not a separately studied compound.

Not medical advice. Educational information reflecting personal research and transparency. GLOW is not FDA-approved as a blend or as individual components for this use. Always work with a qualified healthcare provider before starting any peptide protocol.

GLOW comes up constantly in skin and recovery peptide conversations, and the name is the point: this blend is formulated around visible skin quality and tissue repair, not a single mechanism. It combines three peptides discussed individually elsewhere in Peptide You into one compounded preparation.

The Components

What's Actually In It

BPC-157 is a synthetic pentadecapeptide derived from a protein found in human gastric juice, studied for gut healing, tendon repair, and reducing inflammation. Read the full BPC-157 profile →

TB-500 is a synthetic analog of Thymosin Beta-4, a peptide your body naturally produces for cell migration and tissue repair, with research interest in wound healing and cardiac recovery. Read the full TB-500 profile →

GHK-Cu is a copper peptide naturally present in human plasma that declines with age. It is one of the most studied peptides in skin research, with evidence supporting collagen synthesis, wound healing, and antioxidant effects.[1]

Why Combined

The Logic Behind Stacking

The rationale for combining these three is straightforward: BPC-157 and TB-500 both work on tissue repair through different mechanisms (gut/tendon-focused versus systemic cell migration), and GHK-Cu adds a skin-specific collagen and antioxidant signal on top. Compounding pharmacies that offer this blend are responding to demand from people who want the combined effect without managing three separate injection schedules.

There is no clinical trial of the GLOW blend itself. The rationale is built by combining the individual research bases of the three components, not from a study of the combination.

"GLOW is a compounding convenience, not a studied formula. That distinction matters. The individual peptides have real research behind them. The specific ratio and combination in any given GLOW preparation is determined by the compounding pharmacy, not by a clinical trial."

⚠ FDA / Regulatory StatusNone of the three components, individually or combined, are FDA-approved for this or any human therapeutic use. GHK-Cu is more commonly available as a cosmetic-grade topical ingredient; BPC-157 and TB-500 in injectable form are gray market RUO compounds. Always verify sourcing and discuss with a physician before pursuing any blend protocol.
Cliff's Note

This is one Cheryl has researched closely given her own skin-after-weight-loss work. The individual components each have a real evidence base worth understanding on their own before considering them as part of a blend. See her notes on the Skin page for how this fits into a broader protocol.

Sources & Citations

  1. Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987.